Perioperative glucocorticoid administration for prevention of systemic organ failure in patients undergoing esophageal resection for esophageal carcinoma
- PMID: 16878197
- PMCID: PMC11060359
- DOI: 10.1590/s1516-31802006000200013
Perioperative glucocorticoid administration for prevention of systemic organ failure in patients undergoing esophageal resection for esophageal carcinoma
Abstract
Context and objective: Preoperative glucocorticoid administration has been proposed for reducing postoperative morbidity. This is not widely used before esophageal resection because of incomplete knowledge regarding its effectiveness. The aim here was to assess the effects of preoperative glucocorticoid administration in adults undergoing esophageal resection for esophageal carcinoma.
Search strategy: Studies were identified by searching the Cochrane Controlled Trials Register, MEDLINE, EMBASE, Cancer Lit, SCIELO and Cochrane Library, and by manual searching from relevant articles. The last search for clinical trials for this systematic review was performed in December 2004.
Selection criteria: This review included randomized studies of patients with potentially resectable carcinomas of the esophagus that compared preoperative glucocorticoid administration with placebo.
Data collection and analysis: Data were extracted by the same reviewers, and the trial quality was assessed using Jadad scoring. Relative risk and weighted mean difference with 95% confidence limits were used to assess the significance of the difference between the treatment arms.
Results: Four randomized trials involving 146 patients were found. There were no differences in postoperative mortality, sepsis, anastomotic leakage, hepatic and renal failure between the glucocorticoid and placebo groups. There were fewer postoperative respiratory complications (p = 0.005) and multiple postoperative complications (p = 0.004) and lower postoperative plasma interleukin-6 levels (p = 0.00001) with preoperative glucocorticoid administration. There was a higher postoperative PaO2/FiO2 ratio (p = 0.0001) with preoperative glucocorticoid administration.
Conclusion: Prophylactic administration of glucocorticoids is associated with decreased postoperative complications.
CONTEXTO E OBJETIVO:: A administração de glicocorticóides tem sido proposta para reduzir a morbidade após operações, porém, não é largamente usada antes da ressecção do esôfago devido ao fato de não haver ainda conhecimentos suficientes sobre sua eficácia. O objetivo do trabalho é verificar os efeitos da administração pré-operatória de glicocorticóides em pacientes submetidos a esofagectomia por carcinoma de esôfago.
ESTRATÉGIA DE PESQUISA:: As fontes utilizadas foram: Medline, Embase, Cancerlit, SciELO, Base de Dados de Ensaios Clínicos Controlados da Colaboração Cochrane e busca manual de referências. O término da pesquisa ocorreu em dezembro de 2004.
CRITÉRIOS DE SELEÇÃO:: Estudos randomizados de pacientes com carcinoma esofágico que compararam glicocorticóide com placebo administrados antes das esofagectomias.
ANÁLISE E COLETA DE DADOS:: Os dados foram coletados pelos mesmos revisores e a qualidade dos estudos foi avaliada usando-se o escore de Jadad. A metanálise foi realizada utilizando-se o risco relativo e diferença de média ponderada entre tratamento e placebo (intervalos de confiança de 95%).
RESULTADOS:: Quatroensaios envolvendo 146 pacientes foram localizados. Não ocorreram diferenças na mortalidade pós-operatória e nas incidências de sepse, deiscência de anastomose e insuficiências renal e hepática entre glicocorticóide e placebo. Houve decréscimo na incidência de complicações respiratórias pós-operatórias (p = 0,005), múltiplas complicações (p = 0,004) e níveis plasmáticos de interleucina-6 (p = 0,00001) nos pacientes que receberam glicocorticóide pré-operatório. Houve incremento na relação PaO2/FiO2 pós-operatória (p = 0,0001) no grupo que recebeu glicocorticóide pré-operatório.
CONCLUSÃO:: A administração pré-operatória de glicocorticóide foi associada com um decréscimo nas complicações pós-operatórias.
Conflict of interest statement
Figures
Similar articles
-
Preoperative chemotherapy for resectable thoracic esophageal cancer.Cochrane Database Syst Rev. 2001;(1):CD001556. doi: 10.1002/14651858.CD001556. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2003;(4):CD001556. doi: 10.1002/14651858.CD001556. PMID: 11279723 Updated.
-
Preoperative chemotherapy for resectable thoracic esophageal cancer.Cochrane Database Syst Rev. 2003;(4):CD001556. doi: 10.1002/14651858.CD001556. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2006 Jul 19;(3):CD001556. doi: 10.1002/14651858.CD001556.pub2. PMID: 14583936 Updated.
-
Glucocorticosteroids for infants with biliary atresia following Kasai portoenterostomy.Cochrane Database Syst Rev. 2018 May 14;5(5):CD008735. doi: 10.1002/14651858.CD008735.pub3. Cochrane Database Syst Rev. 2018. PMID: 29761473 Free PMC article.
-
Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus.Cochrane Database Syst Rev. 2001;(2):CD002092. doi: 10.1002/14651858.CD002092. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2003;(1):CD002092. doi: 10.1002/14651858.CD002092. PMID: 11406033 Updated.
-
Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus.Cochrane Database Syst Rev. 2003;(1):CD002092. doi: 10.1002/14651858.CD002092. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2006 Jan 25;(1):CD002092. doi: 10.1002/14651858.CD002092.pub2. PMID: 12535428 Updated.
Cited by
-
Regulating surgical oncotaxis to improve the outcomes in cancer patients.Surg Today. 2014 May;44(5):804-11. doi: 10.1007/s00595-013-0627-0. Epub 2013 Jun 5. Surg Today. 2014. PMID: 23736890 Review.
-
Landiolol hydrochloride for early postoperative tachycardia after transthoracic esophagectomy.Surg Today. 2014 May;44(5):848-54. doi: 10.1007/s00595-013-0615-4. Epub 2013 May 15. Surg Today. 2014. PMID: 23674201
-
Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy.World J Surg. 2010 Feb;34(2):277-84. doi: 10.1007/s00268-009-0331-9. World J Surg. 2010. PMID: 20033687
-
Perioperative corticosteroids for reducing postoperative complications following esophagectomy: an updated systematic review and meta-analysis.BMC Surg. 2024 Feb 15;24(1):57. doi: 10.1186/s12893-024-02342-1. BMC Surg. 2024. PMID: 38360649 Free PMC article.
-
Development of Severe Hyponatremia due to Salt-Losing Nephropathy after Esophagectomy for Esophageal Cancer.Case Rep Med. 2009;2009:241283. doi: 10.1155/2009/241283. Epub 2009 Oct 28. Case Rep Med. 2009. PMID: 19888422 Free PMC article.
References
-
- Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg. 2002;195(5):694–712. - PubMed
-
- Takeda S, Ogawa R, Nakanishi K, et al. The effect of preoperative high dose methylprednisolone in attenuating the metabolic response after oesphageal resection. Eur J Surg. 1997;163(7):511–517. - PubMed
-
- Takeda S, Kim C, Ikezaki H, et al. Preoperative administration of methylprednisolone attenuates cytokine-induced respiratory failure after esophageal resection. J Nippon Med Sch. 2003;70(1):16–20. - PubMed
-
- Raimondi AM. [Esophagitis in the esophageal stump in patients with advanced achalasia and underwent gastric transposition: a long standing clinical and endoscopic appraisal] [dissertation] São Paulo: Faculdade de Medicina da Universidade de São Paulo; 2001. Esofagite no coto esofágico em pacientes submetidos à esofagogastroplastia para tratamento do mega-esôfago avançado: avaliação clínica e endoscópica a longo prazo.
-
- Cecconello I, Rocha JRM, Raimondi AM, Oliveira MA, Gama-Rodrigues JJ. Reflux esophagitis and ectopic columnar epithelium in the esophageal stump after cervical gastroplasty: a reappraisal based on 17 years follow-up [abstract] Gut. 2001;49(Suppl 3):3028–3028.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical